Exposure to SARS-CoV-2 within the household is associated with greater symptom severity and stronger antibody responses in a community-based sample of seropositive adults.
Joshua M Schrock, Daniel T Ryan, Rana Saber, Nanette Benbow, Lauren A Vaught, Nina Reiser, Matthew P Velez, Ryan Hsieh, Michael Newcomb, Alexis R Demonbreun, Brian Mustanski, Elizabeth M McNally, Richard D'Aquila, Thomas W McDade
{"title":"Exposure to SARS-CoV-2 within the household is associated with greater symptom severity and stronger antibody responses in a community-based sample of seropositive adults.","authors":"Joshua M Schrock, Daniel T Ryan, Rana Saber, Nanette Benbow, Lauren A Vaught, Nina Reiser, Matthew P Velez, Ryan Hsieh, Michael Newcomb, Alexis R Demonbreun, Brian Mustanski, Elizabeth M McNally, Richard D'Aquila, Thomas W McDade","doi":"10.1101/2021.03.11.21253421","DOIUrl":null,"url":null,"abstract":"<p><p>Magnitude of SARS-CoV-2 virus exposure may contribute to symptom severity. In a sample of seropositive adults (n=1101), we found that individuals who lived with a known COVID-19 case exhibited greater symptom severity and IgG concentrations compared to individuals who were seropositive but did not live with a known case (P<0.0001).</p>","PeriodicalId":18659,"journal":{"name":"medRxiv : the preprint server for health sciences","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/4f/8b/nihpp-2021.03.11.21253421.PMC7987062.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"medRxiv : the preprint server for health sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1101/2021.03.11.21253421","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Magnitude of SARS-CoV-2 virus exposure may contribute to symptom severity. In a sample of seropositive adults (n=1101), we found that individuals who lived with a known COVID-19 case exhibited greater symptom severity and IgG concentrations compared to individuals who were seropositive but did not live with a known case (P<0.0001).